Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP505266.RAJ9B-goOy1aFtW2I80POtww7Fdi9eOb-JdKKSx0pjbZk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP505266.RAJ9B-goOy1aFtW2I80POtww7Fdi9eOb-JdKKSx0pjbZk130_assertion type Assertion NP505266.RAJ9B-goOy1aFtW2I80POtww7Fdi9eOb-JdKKSx0pjbZk130_head.
- NP505266.RAJ9B-goOy1aFtW2I80POtww7Fdi9eOb-JdKKSx0pjbZk130_assertion description "[GSTM1 and GSTT1 double null genotype was also higher in BPD group (38.3%) than in controls (21.0%) with a higher risk towards BPD (OR: 2.338, 95%CI=1.151-4.751, p=0.017).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505266.RAJ9B-goOy1aFtW2I80POtww7Fdi9eOb-JdKKSx0pjbZk130_provenance.
- NP505266.RAJ9B-goOy1aFtW2I80POtww7Fdi9eOb-JdKKSx0pjbZk130_assertion evidence source_evidence_literature NP505266.RAJ9B-goOy1aFtW2I80POtww7Fdi9eOb-JdKKSx0pjbZk130_provenance.
- NP505266.RAJ9B-goOy1aFtW2I80POtww7Fdi9eOb-JdKKSx0pjbZk130_assertion SIO_000772 24120392 NP505266.RAJ9B-goOy1aFtW2I80POtww7Fdi9eOb-JdKKSx0pjbZk130_provenance.
- NP505266.RAJ9B-goOy1aFtW2I80POtww7Fdi9eOb-JdKKSx0pjbZk130_assertion wasDerivedFrom befree-20140225 NP505266.RAJ9B-goOy1aFtW2I80POtww7Fdi9eOb-JdKKSx0pjbZk130_provenance.
- NP505266.RAJ9B-goOy1aFtW2I80POtww7Fdi9eOb-JdKKSx0pjbZk130_assertion wasGeneratedBy ECO_0000203 NP505266.RAJ9B-goOy1aFtW2I80POtww7Fdi9eOb-JdKKSx0pjbZk130_provenance.